CHARLESTON, S.C.--(BUSINESS WIRE)--Plasma Technologies LLC (PlasmaTech), a plasma biologics technology company, announced that its novel human plasma fractionation process has been shown to achieve a ...

The starting material for virtually all pharmaceuticals and biologics is a synthetic or chemical. Human plasma-derived therapies are one of the few exceptions. A number of fragile proteins can be ...

Every day, thousands of Indonesians donate blood and plasma, often unaware of the complex scientific and safety-driven processes that transform a single donation into life-saving therapies. As ...

IRVING, Texas--(BUSINESS WIRE)--Fluor Corporation (NYSE: FLR) announced today that Grifols’ North Fractionation Facility in Clayton, N.C., was named the International Society for Pharmaceutical ...

The plasma fractionation market is projected to reach US$ 40,731.98 million by 2028 from US$ 26,575.83 million in 2021; it is expected to grow at a CAGR of 6.3% during 2021-2028. According to the ...

Ottawa, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The global plasma fractionation market size was valued at USD 35.22 billion in 2024 and is predicted to hit around USD 72.86 billion by 2034, rising at a 7.54 ...

The global plasma fractionation market can be segmented by product type, application, end-user, and geography. Some of the key players in the global plasma fractionation market include CSL Behring LLC ...

Dublin, Sept. 25, 2020 (GLOBE NEWSWIRE) -- The "Plasma Fractionation Market by Product (IVIG, Albumin, Factor VIII, von Willebrand Factor, PCC, Protease Inhibitor ...

(MENAFN- EIN Presswire) EINPresswire/ -- What Is The Expected Cagr For The Plasma Fractionation Market Through 2025? The size of the plasma fractionation market has seen considerable growth in the ...

This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in ...